MCID: AGN003
MIFTS: 46

Agenesis of the Corpus Callosum with Peripheral Neuropathy

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Fetal diseases, Skin diseases

Aliases & Classifications for Agenesis of the Corpus Callosum with Peripheral Neuropathy

MalaCards integrated aliases for Agenesis of the Corpus Callosum with Peripheral Neuropathy:

Name: Agenesis of the Corpus Callosum with Peripheral Neuropathy 57 12 12 37 13 15
Andermann Syndrome 57 12 24 53 25 59 75 29 55 6
Charlevoix Disease 57 12 53 25 59 75
Hereditary Motor and Sensory Neuropathy with Agenesis of the Corpus Callosum 12 24 53 25 15
Accpn 57 24 53 25 75
Polyneuropathy, Sensorimotor, with or Without Agenesis of the Corpus Callosum 57 53 75
Agenesis of Corpus Callosum with Peripheral Neuropathy 24 53 25
Agenesis of Corpus Callosum with Polyneuropathy 24 53 25
Corpus Callosum Agenesis Neuronopathy 53 44 73
Hmsn/acc 24 53 25
Corpus Callosum, Agenesis of, with Neuronopathy 57 75
Corpus Callosum Agenesis-Neuronopathy Syndrome 12 59
Agenesis of Corpus Callosum with Neuronopathy 53 25
Peripheral Neuropathy Associated with Agenesis of the Corpus Callosum 12
Agenesis of the Corpus Callosum, with Peripheral Neuropathy 75
Agenesis, Corpus Callosum, with Peripheral Neuropathy 40
Andermann's Syndrome 75

Characteristics:

Orphanet epidemiological data:

59
corpus callosum agenesis-neuronopathy syndrome
Inheritance: Autosomal recessive; Age of onset: Antenatal,Neonatal;

OMIM:

57
Inheritance:
autosomal recessive

Miscellaneous:
progressive disorder
onset within the first year of life
most individuals are wheelchair-bound or bedridden by adolescence
death in third or fourth decades, usually due to respiratory infection
increased frequency in the charlevoix and saguenat-lac-st-jean regions of quebec, canada (1 in 2,117 live births, carrier rate 1 in 23)


HPO:

32
agenesis of the corpus callosum with peripheral neuropathy:
Onset and clinical course progressive
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Agenesis of the Corpus Callosum with Peripheral Neuropathy

NIH Rare Diseases : 53 Andermann syndrome (AS) is a disorder that damages the nerves used for muscle movement and sensation (motor and sensory neuropathy). Agenesis or malformation of the corpus callosum also occurs in most people with this disorder. Signs and symptoms of the disorder include areflexia; hypotonia; amyotrophy; severe progressive weakness and loss of sensation in the limbs; and tremors. Affected individuals typically begin walking late and lose this ability by their teenage years. Other features may include intellectual disability, seizures, contractures, scoliosis, various psychiatric symptoms, various atypical physical features, and cranial nerve problems that cause facial muscle weakness, ptosis, and difficulty following movements with the eyes (gaze palsy). It is caused by mutations in the SLC12A6 gene and is inherited in an autosomal recessive manner. AS is associated with a shortened life expectancy, but affected individuals typically live into adulthood.

MalaCards based summary : Agenesis of the Corpus Callosum with Peripheral Neuropathy, also known as andermann syndrome, is related to kuzniecky andermann syndrome and corpus callosum, agenesis of, and has symptoms including seizures and tremor, limb. An important gene associated with Agenesis of the Corpus Callosum with Peripheral Neuropathy is SLC12A6 (Solute Carrier Family 12 Member 6), and among its related pathways/superpathways is Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds. Affiliated tissues include brain, eye and testes, and related phenotypes are agenesis of corpus callosum and nystagmus

OMIM : 57 Andermann syndrome is an autosomal recessive motor and sensory neuropathy with agenesis of the corpus callosum associated with developmental and neurodegenerative defects and dysmorphic features. It has a high prevalence in the French Canadian population in the Charlevoix and Saguenay-Lac-Saint-Jean region of Quebec (Uyanik et al., 2006). Dupre et al. (2003) provided a comprehensive review of the disorder. Dobyns (1996) reviewed the many genetic causes of agenesis of the corpus callosum. (218000)

UniProtKB/Swiss-Prot : 75 Agenesis of the corpus callosum, with peripheral neuropathy: A disease that is characterized by severe progressive sensorimotor neuropathy, mental retardation, dysmorphic features and complete or partial agenesis of the corpus callosum.

Genetics Home Reference : 25 Andermann syndrome is a disorder that damages the nerves used for muscle movement and sensation (motor and sensory neuropathy). Absence (agenesis) or malformation of the tissue connecting the left and right halves of the brain (corpus callosum) also occurs in most people with this disorder.

Disease Ontology : 12 A neuropathy that has material basis in homozygous or compound heterozygous mutation in the SLC12A6 gene on chromosome 15q14. It is an autosomal recessive disease of early onset characterized by a delay in developmental milestones, a severe sensory-motor polyneuropathy with areflexia, a variable degree of agenesis of the corpus callosum, amyotrophy, hypotonia, and cognitive impairment.

Wikipedia : 76 Andermann syndrome also known as agenesis of corpus callosum with neuronopathy (ACCPN), Charlevoix... more...

GeneReviews: NBK1372

Related Diseases for Agenesis of the Corpus Callosum with Peripheral Neuropathy

Graphical network of the top 20 diseases related to Agenesis of the Corpus Callosum with Peripheral Neuropathy:



Diseases related to Agenesis of the Corpus Callosum with Peripheral Neuropathy

Symptoms & Phenotypes for Agenesis of the Corpus Callosum with Peripheral Neuropathy

Symptoms via clinical synopsis from OMIM:

57
Head And Neck Eyes:
hypertelorism
ptosis
gaze palsies

Skeletal Spine:
scoliosis

Muscle Soft Tissue:
neonatal hypotonia
amyotrophy
progressive distal and proximal symmetric limb weakness
emg shows denervation

Head And Neck Face:
long face
facial asymmetry
narrow forehead
facial diplegia
hypoplastic maxilla

Laboratory Abnormalities:
increased csf protein

Head And Neck Ears:
large ears

Skin Nails Hair Hair:
low hairline

Skeletal Hands:
long tapered fingers

Neurologic Behavioral Psychiatric Manifestations:
hallucinatory psychosis develops during adolescence

Neurologic Central Nervous System:
seizures
developmental delay
enlarged ventricles
agenesis of the corpus callosum
delayed motor milestones
more
Head And Neck Nose:
short nose
broad nasal root

Head And Neck Head:
brachycephaly

Neurologic Peripheral Nervous System:
areflexia
peripheral motor neuropathy, severe
peripheral sensory neuropathy, severe
limb tremor
sural nerve biopsy shows absence of large myelinated fibers
more
Head And Neck Mouth:
high-arched palate
protruding, fissured tongue

Skeletal:
joint contractures

Respiratory:
restrictive respiratory disease

Skeletal Feet:
syndactyly of the second and third toes
overriding of the first toe


Clinical features from OMIM:

218000

Human phenotypes related to Agenesis of the Corpus Callosum with Peripheral Neuropathy:

59 32 (show top 50) (show all 52)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 agenesis of corpus callosum 59 32 hallmark (90%) Very frequent (99-80%) HP:0001274
2 nystagmus 59 32 occasional (7.5%) Occasional (29-5%) HP:0000639
3 intellectual disability 59 32 hallmark (90%) Very frequent (99-80%) HP:0001249
4 seizures 59 32 hallmark (90%) Very frequent (99-80%) HP:0001250
5 eeg abnormality 59 32 hallmark (90%) Very frequent (99-80%) HP:0002353
6 aqueductal stenosis 59 32 frequent (33%) Frequent (79-30%) HP:0002410
7 global developmental delay 59 32 hallmark (90%) Very frequent (99-80%) HP:0001263
8 microcephaly 59 32 hallmark (90%) Very frequent (99-80%) HP:0000252
9 abnormality of retinal pigmentation 59 32 occasional (7.5%) Occasional (29-5%) HP:0007703
10 hemiplegia/hemiparesis 59 32 hallmark (90%) Very frequent (99-80%) HP:0004374
11 strabismus 59 32 occasional (7.5%) Occasional (29-5%) HP:0000486
12 myopia 59 32 occasional (7.5%) Occasional (29-5%) HP:0000545
13 turricephaly 59 32 occasional (7.5%) Occasional (29-5%) HP:0000262
14 craniosynostosis 59 32 occasional (7.5%) Occasional (29-5%) HP:0001363
15 hypertelorism 32 HP:0000316
16 high palate 32 HP:0000218
17 ptosis 32 HP:0000508
18 scoliosis 32 HP:0002650
19 macrotia 32 HP:0000400
20 wide nasal bridge 32 HP:0000431
21 short nose 32 HP:0003196
22 neonatal hypotonia 32 HP:0001319
23 flexion contracture 32 HP:0001371
24 brachycephaly 32 HP:0000248
25 skeletal muscle atrophy 32 HP:0003202
26 sensory neuropathy 32 HP:0000763
27 decreased motor nerve conduction velocity 32 HP:0003431
28 ventriculomegaly 32 HP:0002119
29 psychosis 32 HP:0000709
30 hypoplasia of the maxilla 32 HP:0000327
31 long face 32 HP:0000276
32 areflexia 32 HP:0001284
33 low anterior hairline 32 HP:0000294
34 facial asymmetry 32 HP:0000324
35 tapered finger 32 HP:0001182
36 motor delay 32 HP:0001270
37 polyneuropathy 32 HP:0001271
38 limb muscle weakness 32 HP:0003690
39 restrictive deficit on pulmonary function testing 32 HP:0002111
40 generalized hypotonia 32 HP:0001290
41 2-3 toe syndactyly 32 HP:0004691
42 increased csf protein 32 HP:0002922
43 peripheral axonal neuropathy 32 HP:0003477
44 narrow forehead 32 HP:0000341
45 onion bulb formation 32 HP:0003383
46 decreased sensory nerve conduction velocity 32 HP:0003448
47 motor polyneuropathy 32 HP:0007178
48 respiratory tract infection 32 HP:0011947
49 facial diplegia 32 HP:0001349
50 limb tremor 32 HP:0200085

UMLS symptoms related to Agenesis of the Corpus Callosum with Peripheral Neuropathy:


seizures, tremor, limb

MGI Mouse Phenotypes related to Agenesis of the Corpus Callosum with Peripheral Neuropathy:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.86 SLC12A6 SLC12A7 CLCN2 FA2H HPGDS PVALB
2 nervous system MP:0003631 9.61 CLCN2 FA2H HPGDS PVALB SLC12A2 SLC12A5
3 hearing/vestibular/ear MP:0005377 9.46 SLC12A2 SLC12A5 SLC12A6 SLC12A7
4 vision/eye MP:0005391 9.1 CLCN2 FA2H SLC12A5 SLC12A6 SLC12A7 VAV2

Drugs & Therapeutics for Agenesis of the Corpus Callosum with Peripheral Neuropathy

Search Clinical Trials , NIH Clinical Center for Agenesis of the Corpus Callosum with Peripheral Neuropathy

Cochrane evidence based reviews: corpus callosum agenesis neuronopathy

Genetic Tests for Agenesis of the Corpus Callosum with Peripheral Neuropathy

Genetic tests related to Agenesis of the Corpus Callosum with Peripheral Neuropathy:

# Genetic test Affiliating Genes
1 Andermann Syndrome 29 SLC12A6

Anatomical Context for Agenesis of the Corpus Callosum with Peripheral Neuropathy

MalaCards organs/tissues related to Agenesis of the Corpus Callosum with Peripheral Neuropathy:

41
Brain, Eye, Testes, Tongue, Skeletal Muscle

Publications for Agenesis of the Corpus Callosum with Peripheral Neuropathy

Articles related to Agenesis of the Corpus Callosum with Peripheral Neuropathy:

# Title Authors Year
1
A new patient with Andermann syndrome: an underdiagnosed clinical genetics entity? ( 24341143 )
2013
2
Andermann syndrome can be a phenocopy of hereditary motor and sensory neuropathy--report of a discordant sibship with a compound heterozygous mutation of the KCC3 gene. ( 20020398 )
2009
3
Novel truncating and missense mutations of the KCC3 gene associated with Andermann syndrome. ( 16606917 )
2006
4
Corpus callosum agenesis and psychosis in Andermann syndrome. ( 1668979 )
1991

Variations for Agenesis of the Corpus Callosum with Peripheral Neuropathy

ClinVar genetic disease variations for Agenesis of the Corpus Callosum with Peripheral Neuropathy:

6
(show top 50) (show all 262)
# Gene Variation Type Significance SNP ID Assembly Location
1 SLC12A6 NM_133647.1(SLC12A6): c.3031C> T (p.Arg1011Ter) single nucleotide variant Pathogenic rs121908427 GRCh37 Chromosome 15, 34528920: 34528920
2 SLC12A6 NM_133647.1(SLC12A6): c.3031C> T (p.Arg1011Ter) single nucleotide variant Pathogenic rs121908427 GRCh38 Chromosome 15, 34236719: 34236719
3 SLC12A6 NM_133647.1(SLC12A6): c.2023C> T (p.Arg675Ter) single nucleotide variant Pathogenic rs121908428 GRCh37 Chromosome 15, 34536194: 34536194
4 SLC12A6 NM_133647.1(SLC12A6): c.2023C> T (p.Arg675Ter) single nucleotide variant Pathogenic rs121908428 GRCh38 Chromosome 15, 34243993: 34243993
5 SLC12A6 NM_005135.2(SLC12A6): c.748delA (p.Ile250Serfs) deletion Pathogenic rs606231157 GRCh38 Chromosome 15, 34254565: 34254565
6 SLC12A6 NM_005135.2(SLC12A6): c.748delA (p.Ile250Serfs) deletion Pathogenic rs606231157 GRCh37 Chromosome 15, 34546766: 34546766
7 SLC12A6 NM_005135.2(SLC12A6): c.466C> T (p.Arg156Cys) single nucleotide variant Pathogenic rs121908429 GRCh37 Chromosome 15, 34549914: 34549914
8 SLC12A6 NM_005135.2(SLC12A6): c.466C> T (p.Arg156Cys) single nucleotide variant Pathogenic rs121908429 GRCh38 Chromosome 15, 34257713: 34257713
9 SLC12A6 NM_005135.2(SLC12A6): c.2841_2850delCCAGATGCTC (p.Gln948Glyfs) deletion Pathogenic rs606231158 GRCh38 Chromosome 15, 34236747: 34236756
10 SLC12A6 NM_005135.2(SLC12A6): c.2841_2850delCCAGATGCTC (p.Gln948Glyfs) deletion Pathogenic rs606231158 GRCh37 Chromosome 15, 34528948: 34528957
11 SLC12A6 NM_005135.2(SLC12A6): c.3247C> T (p.Arg1083Ter) single nucleotide variant Pathogenic rs606231229 GRCh38 Chromosome 15, 34233934: 34233934
12 SLC12A6 NM_005135.2(SLC12A6): c.3247C> T (p.Arg1083Ter) single nucleotide variant Pathogenic rs606231229 GRCh37 Chromosome 15, 34526135: 34526135
13 SLC12A6 NM_133647.1(SLC12A6): c.1584_1585delCTinsG (p.Phe529Leufs) indel Pathogenic rs515726216 GRCh38 Chromosome 15, 34250637: 34250638
14 SLC12A6 NM_133647.1(SLC12A6): c.1584_1585delCTinsG (p.Phe529Leufs) indel Pathogenic rs515726216 GRCh37 Chromosome 15, 34542838: 34542839
15 SLC12A6 NM_005135.2(SLC12A6): c.1879dupT (p.Tyr627Leufs) duplication Pathogenic rs515726217 GRCh38 Chromosome 15, 34243984: 34243984
16 SLC12A6 NM_005135.2(SLC12A6): c.1879dupT (p.Tyr627Leufs) duplication Pathogenic rs515726217 GRCh37 Chromosome 15, 34536185: 34536185
17 SLC12A6 NM_133647.1(SLC12A6): c.1478_1485delTTCCCTCT (p.Phe493Cysfs) deletion Pathogenic rs515726218 GRCh38 Chromosome 15, 34250906: 34250913
18 SLC12A6 NM_133647.1(SLC12A6): c.1478_1485delTTCCCTCT (p.Phe493Cysfs) deletion Pathogenic rs515726218 GRCh37 Chromosome 15, 34543107: 34543114
19 SLC12A6 NM_133647.1(SLC12A6): c.3003C> T (p.Leu1001=) single nucleotide variant Benign rs4577050 GRCh37 Chromosome 15, 34528948: 34528948
20 SLC12A6 NM_133647.1(SLC12A6): c.3003C> T (p.Leu1001=) single nucleotide variant Benign rs4577050 GRCh38 Chromosome 15, 34236747: 34236747
21 SLC12A6 NM_133647.1(SLC12A6): c.2934+12G> C single nucleotide variant Benign/Likely benign rs11854257 GRCh37 Chromosome 15, 34529608: 34529608
22 SLC12A6 NM_133647.1(SLC12A6): c.2934+12G> C single nucleotide variant Benign/Likely benign rs11854257 GRCh38 Chromosome 15, 34237407: 34237407
23 SLC12A6 NM_133647.1(SLC12A6): c.1825-13C> T single nucleotide variant Benign/Likely benign rs74010036 GRCh37 Chromosome 15, 34537617: 34537617
24 SLC12A6 NM_133647.1(SLC12A6): c.1825-13C> T single nucleotide variant Benign/Likely benign rs74010036 GRCh38 Chromosome 15, 34245416: 34245416
25 SLC12A6 NM_133647.1(SLC12A6): c.1284C> T (p.Asn428=) single nucleotide variant Conflicting interpretations of pathogenicity rs34098566 GRCh37 Chromosome 15, 34544420: 34544420
26 SLC12A6 NM_133647.1(SLC12A6): c.1284C> T (p.Asn428=) single nucleotide variant Conflicting interpretations of pathogenicity rs34098566 GRCh38 Chromosome 15, 34252219: 34252219
27 SLC12A6 NM_133647.1(SLC12A6): c.1005C> T (p.Ile335=) single nucleotide variant Uncertain significance rs35855196 GRCh37 Chromosome 15, 34546662: 34546662
28 SLC12A6 NM_133647.1(SLC12A6): c.1005C> T (p.Ile335=) single nucleotide variant Uncertain significance rs35855196 GRCh38 Chromosome 15, 34254461: 34254461
29 SLC12A6 NM_133647.1(SLC12A6): c.940A> T (p.Met314Leu) single nucleotide variant Uncertain significance rs34491959 GRCh37 Chromosome 15, 34546727: 34546727
30 SLC12A6 NM_133647.1(SLC12A6): c.940A> T (p.Met314Leu) single nucleotide variant Uncertain significance rs34491959 GRCh38 Chromosome 15, 34254526: 34254526
31 SLC12A6 NM_133647.1(SLC12A6): c.475C> T (p.Leu159=) single nucleotide variant Benign rs7164902 GRCh37 Chromosome 15, 34551082: 34551082
32 SLC12A6 NM_133647.1(SLC12A6): c.475C> T (p.Leu159=) single nucleotide variant Benign rs7164902 GRCh38 Chromosome 15, 34258881: 34258881
33 SLC12A6 NM_133647.1(SLC12A6): c.379G> T (p.Glu127Ter) single nucleotide variant Pathogenic rs199747285 GRCh37 Chromosome 15, 34553159: 34553159
34 SLC12A6 NM_133647.1(SLC12A6): c.379G> T (p.Glu127Ter) single nucleotide variant Pathogenic rs199747285 GRCh38 Chromosome 15, 34260958: 34260958
35 SLC12A6 NM_133647.1(SLC12A6): c.571_572dupGT (p.Tyr192Serfs) duplication Likely pathogenic rs775111365 GRCh37 Chromosome 15, 34549961: 34549962
36 SLC12A6 NM_133647.1(SLC12A6): c.571_572dupGT (p.Tyr192Serfs) duplication Likely pathogenic rs775111365 GRCh38 Chromosome 15, 34257760: 34257761
37 SLC12A6 NM_133647.1(SLC12A6): c.3042+8A> G single nucleotide variant Conflicting interpretations of pathogenicity rs186141509 GRCh37 Chromosome 15, 34528901: 34528901
38 SLC12A6 NM_133647.1(SLC12A6): c.3042+8A> G single nucleotide variant Conflicting interpretations of pathogenicity rs186141509 GRCh38 Chromosome 15, 34236700: 34236700
39 SLC12A6 NM_133647.1(SLC12A6): c.1412G> C (p.Ser471Thr) single nucleotide variant Conflicting interpretations of pathogenicity rs140916001 GRCh37 Chromosome 15, 34543180: 34543180
40 SLC12A6 NM_133647.1(SLC12A6): c.1412G> C (p.Ser471Thr) single nucleotide variant Conflicting interpretations of pathogenicity rs140916001 GRCh38 Chromosome 15, 34250979: 34250979
41 SLC12A6 NM_133647.1(SLC12A6): c.*3525C> T single nucleotide variant Likely benign rs1133154 GRCh37 Chromosome 15, 34522557: 34522557
42 SLC12A6 NM_133647.1(SLC12A6): c.*3525C> T single nucleotide variant Likely benign rs1133154 GRCh38 Chromosome 15, 34230356: 34230356
43 SLC12A6 NM_133647.1(SLC12A6): c.*3520C> G single nucleotide variant Uncertain significance rs886051036 GRCh37 Chromosome 15, 34522562: 34522562
44 SLC12A6 NM_133647.1(SLC12A6): c.*3520C> G single nucleotide variant Uncertain significance rs886051036 GRCh38 Chromosome 15, 34230361: 34230361
45 SLC12A6 NM_133647.1(SLC12A6): c.*2852T> C single nucleotide variant Uncertain significance rs117020610 GRCh38 Chromosome 15, 34231029: 34231029
46 SLC12A6 NM_133647.1(SLC12A6): c.*2852T> C single nucleotide variant Uncertain significance rs117020610 GRCh37 Chromosome 15, 34523230: 34523230
47 SLC12A6 NM_133647.1(SLC12A6): c.*3097G> C single nucleotide variant Benign rs4238571 GRCh37 Chromosome 15, 34522985: 34522985
48 SLC12A6 NM_133647.1(SLC12A6): c.*3097G> C single nucleotide variant Benign rs4238571 GRCh38 Chromosome 15, 34230784: 34230784
49 SLC12A6 NM_133647.1(SLC12A6): c.*2909delT deletion Uncertain significance rs886051039 GRCh37 Chromosome 15, 34523173: 34523173
50 SLC12A6 NM_133647.1(SLC12A6): c.*2909delT deletion Uncertain significance rs886051039 GRCh38 Chromosome 15, 34230972: 34230972

Expression for Agenesis of the Corpus Callosum with Peripheral Neuropathy

Search GEO for disease gene expression data for Agenesis of the Corpus Callosum with Peripheral Neuropathy.

Pathways for Agenesis of the Corpus Callosum with Peripheral Neuropathy

GO Terms for Agenesis of the Corpus Callosum with Peripheral Neuropathy

Cellular components related to Agenesis of the Corpus Callosum with Peripheral Neuropathy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 integral component of plasma membrane GO:0005887 9.1 CLCN2 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7
2 terminal bouton GO:0043195 8.96 PVALB TBC1D24

Biological processes related to Agenesis of the Corpus Callosum with Peripheral Neuropathy according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 ion transport GO:0006811 9.93 CLCN2 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7
2 transmembrane transport GO:0055085 9.91 CLCN2 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7
3 chemical synaptic transmission GO:0007268 9.8 SLC12A4 SLC12A5 SLC12A6 SLC12A7
4 potassium ion transport GO:0006813 9.8 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7
5 potassium ion transmembrane transport GO:0071805 9.77 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7
6 chloride transmembrane transport GO:1902476 9.73 CLCN2 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7
7 potassium ion import GO:0010107 9.72 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7
8 chloride transport GO:0006821 9.69 CLCN2 SLC12A2 SLC12A5
9 cell volume homeostasis GO:0006884 9.55 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7
10 cellular hypotonic salinity response GO:0071477 9.48 SLC12A4 SLC12A6
11 potassium ion homeostasis GO:0055075 9.35 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7
12 chloride ion homeostasis GO:0055064 9.02 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7

Molecular functions related to Agenesis of the Corpus Callosum with Peripheral Neuropathy according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 symporter activity GO:0015293 9.55 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7
2 potassium:chloride symporter activity GO:0015379 9.35 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7
3 cation:chloride symporter activity GO:0015377 9.02 SLC12A2 SLC12A4 SLC12A5 SLC12A6 SLC12A7

Sources for Agenesis of the Corpus Callosum with Peripheral Neuropathy

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....